KBG syndrome presenting with brachydactyly type E.


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
06 2019
Historique:
received: 19 12 2018
revised: 05 03 2019
accepted: 11 03 2019
pubmed: 17 3 2019
medline: 21 7 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

We report the case of a young woman who presented at age 10 years with height on the tenth centile, brachydactyly type E and mild developmental delay. Biochemistry and hormonal profiles were normal. Differential diagnoses considered included Albright hereditary osteodystrophy without hormone resistance (a.k.a pseudopseudohypoparathyroidism), 2q37 microdeletion syndrome and acrodysostosis. She had a normal karyotype and normal FISH of 2q37. Whole genome sequencing (WGS) identified a mutation in the ANKRD11 gene associated with KBG syndrome. We review the clinical features of the genetic syndromes considered, and suggest KBG syndrome be considered in patients presenting with syndromic brachydactyly type E, especially if short stature and developmental delay are also present.

Identifiants

pubmed: 30877071
pii: S8756-3282(19)30088-2
doi: 10.1016/j.bone.2019.03.012
pii:
doi:

Substances chimiques

ANKRD11 protein, human 0
Repressor Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-22

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Renata Libianto (R)

Bone Division, Garvan Institute of Medical Research, Sydney, Australia; Department of Endocrinology, St Vincent's Hospital Sydney, Australia; Department of Medicine, The University of Melbourne, Australia. Electronic address: renata.libianto@monash.edu.

Kathy Hc Wu (KH)

Clinical Genomics Unit, St Vincent's Hospital Sydney, Australia; Discipline of Genetic Medicine, University of Sydney, Australia; School of Medicine, UNSW, Sydney, Australia; Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.

Sophie Devery (S)

Clinical Genomics Unit, St Vincent's Hospital Sydney, Australia.

John A Eisman (JA)

Bone Division, Garvan Institute of Medical Research, Sydney, Australia; Department of Endocrinology, St Vincent's Hospital Sydney, Australia; School of Medicine, UNSW, Sydney, Australia; School of Medicine Sydney, University of Notre Dame, Australia.

Jackie R Center (JR)

Bone Division, Garvan Institute of Medical Research, Sydney, Australia; Department of Endocrinology, St Vincent's Hospital Sydney, Australia; School of Medicine, UNSW, Sydney, Australia; School of Medicine Sydney, University of Notre Dame, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH